Untitled Document
![PDF] FibroScan (vibration-controlled transient elastography): where does it stand in the United States practice. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/d1443873eaff02b60860bb714f18a57a40088a5c/2-Figure1-1.png "PDF] FibroScan (vibration-controlled transient elastography): where does it stand in the United States practice. | Semantic Scholar")
PDF] FibroScan (vibration-controlled transient elastography): where does it stand in the United States practice. | Semantic Scholar
Risk-stratified screening for chronic liver disease using vibration-controlled transient elastography (Fibroscan) | Gastrointestinal Nursing
Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography - Myers - 2012 - Liver International - Wiley Online Library
Non-Invasive Assessment of Liver Fibrosis by Vibration-Controlled Transient Elastography (Fibroscan®) | IntechOpen
Performance of Controlled Attenuation Parameter in Patients with Advanced Chronic Liver Disease and Portal Hypertension | SpringerLink
FibroScan® 402 – KNS Canada Inc.
Methods used for liver evaluation: a) Transient Elastography (TE) and... | Download Scientific Diagram
Vibration-controlled Transient Elastography for Assessment of Liver Fibrosis at a USA Academic Medical Center
IJMS | Free Full-Text | Elastography Techniques for the Assessment of Liver Fibrosis in Non-Alcoholic Fatty Liver Disease | HTML
Measurement of Liver Stiffness and Liver Fat Using Vibration-Controlled Transient Elastography Has Excellent Reproducibility and Intra-Operator Reliability in an Unselected Community-Based Cohort | Internal Medicine Residency Program
The controlled attenuation parameter (CAP): A novel tool for the non-invasive evaluation of steatosis using Fibroscan® - ScienceDirect
Noninvasive imaging biomarker assessment of liver fibrosis by elastography in NAFLD | Nature Reviews Gastroenterology & Hepatology
Performance characteristics of vibration‐controlled transient elastography for evaluation of nonalcoholic fatty liver disease - Vuppalanchi - 2018 - Hepatology - Wiley Online Library
PDF) Novel controlled attenuation parameter for noninvasive assessment of steatosis using Fibroscan(®): validation in chronic hepatitis C | veronique miette - Academia.edu
Frontiers | Associations of Uric Acid With Liver Steatosis and Fibrosis Applying Vibration Controlled Transient Elastography in the United States: A Nationwide Cross-Section Study
FibroScan (Vibration-Controlled Transient Elastography): Where Does It Stand in the United States Practice - Clinical Gastroenterology and Hepatology
Individual patient data meta-analysis of controlled attenuation parameter ( CAP) technology for assessing steatosis - ScienceDirect
FibroScan®, transient elastography for liver stiffness - ECHOSENS
Application of transient elastography in nonalcoholic fatty liver disease
Accuracy of controlled attenuation parameter (CAP) and liver stiffness measurement (LSM) for assessing steatosis and fibrosis in non-alcoholic fatty liver disease: A systematic review and meta-analysis - eClinicalMedicine
PREVALENCE AND RISK FACTORS OF HEPATIC STEATOSIS AND FIBROSIS IN AMERICAN ADULTS: A POPULATION-BASED STUDY
Diagnostic accuracy of controlled attenuation parameter (CAP) as a non-invasive test for steatosis in suspected non-alcoholic fatty liver disease: a systematic review and meta-analysis | BMC Gastroenterology | Full Text
Accuracy of FibroScan Controlled Attenuation Parameter and Liver Stiffness Measurement in Assessing Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease - ScienceDirect
